← Return to ALK mutation: Getting alectinib targeted therapy for stage 4 NSCLC
DiscussionALK mutation: Getting alectinib targeted therapy for stage 4 NSCLC
Lung Cancer | Last Active: Nov 24, 2019 | Replies (6)Comment receiving replies
Replies to "I have a sibling who was diagnosed in May 2018 with stage 4 ncslc. He started..."
Wonderful to hear! Thank you!